Obesity management Market is expected to reach US$ 6.2 billion by 2022 from US$ 4.17 billion in 2015. However, several side effects of drugs, regulatory issues and high cost are the major restraints for the market.
MarketResearchFuture.com adds “Obesity Management Market – 2018 Global Analysis, Growth, Trends and Opportunities Research Report forecasting to 2022” reports to its database.
TRY FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/2690 .
The intense need for in-depth understanding of the “Obesity Management Market -Forecast to 2022″ coupled with its high growth potential necessitated the development of this report by Market Research Future. The report specifically focuses on the key industry development trends and forces that shapes the market, but not limited to only commercial nature, but which encompasses a broad range such as social, technological and others.
Depending on geographic region, Obesity Management Market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, North America comprise largest market share in global Obesity Management Market. Moreover the European market is also growing continuously. On the other hand, Asia-Pacific market is expected to grow at the significant rate in the Obesity Management Market segment during the forecasted period. Rest of the World is likely to have a limited but steady growth in the market.
Obesity management Market has been segmented on the basis of Prescription weight-loss medication which comprise orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), and liraglutide (Saxenda), and others. On the basis of Surgery it segmented into Gastric bypass surgery, Laparoscopic adjustable gastric banding (LAGB), Biliopancreatic diversion with duodenal switch, and others. On the basis of lifestyle changes, it is segmented into Dietary changes, Exercise, and others.
The report for Obesity Management Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Global Obesity Management Market Players:
There are plenty of large and small market players which operate in this market all over the globe are Pfizer Inc.(US), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.(US), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (UK), AstraZeneca (UK), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.)
The Global Obesity Management Market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Obesity occurs due to energy imbalance between calories intake and calories expanded. Obesity affects health and can lead to various diseases like heart diseases, stroke, diabetes, hypertension etc. Changing lifestyle such as eating junk food or energy dense food that are high percentage of fat, low physical activity are the major factors that leads to obesity. The population of obese people has doubled since 1980. According to World Health Organization (WHO), in 2014, more than 1.9 billion adults, 18 years and older, were overweight. Out of these over 600 million were obese and about 39% of adults were underweight and out of these 13% were obese. Most of the countries of the World are facing the problem of obesity. Earlier high income countries were facing the problem of obesity and overweight but now problem of obesity is on rise in low and middle income countries. Obesity can be prevented by some dietary changes and exercise. Consumers are becoming more conscious about their health which is driving the growth for the obesity management market. Drugs manufacturers’ spending money in R&D to develop new drugs and supplements. Healthcare solution provider companies are also providing advance solutions for hospitals. Global Obesity Management Market was about US$ 4.17 billion in 2015 and is expected to reach US$ 6.2 billion by 2022 at a CAGR of 8.2%.
Obesity Management Market has been segmented on the basis of Prescription weight-loss medication which comprise orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), and liraglutide (Saxenda), and others. On the basis of Surgery it segmented into Gastric bypass surgery, Laparoscopic adjustable gastric banding (LAGB), Biliopancreatic diversion with duodenal switch, and others. On the basis of lifestyle changes it is segmented into Dietary changes, Exercise, and others.
Table of Content:
Chapter 1. Report Prologue
Chapter 2. Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
Chapter 3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
Chapter 4. Market Dynamics
4.4 Mega Trends
4.5 Macroeconomic Indicators
Chapter 5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger And Acquisition Landscape
5.9 Upcoming Trends
5.9.1 Market Trends
5.9.2 Technological Trends
5.9.3 Insurance & Regulations
Chapter 6. Global Obesity Management Market By Prescription Weight-Loss Medication
Chapter 7. Global Obesity Management Market By Surgery
Chapter 8. Global Obesity Management Market By End User
Chapter 9. Global Obesity Management Market By Region
9.2.1 North America
188.8.131.52 The US
9.2.2 South America
9.3.1 Western Europe
184.108.40.206 Rest Of Western Europe
9.3.2 Eastern Europe
9.4.4 South Korea
9.4.5 Rest Of Asia
9.6 Rest Of The World (RoW)
AVAIL AMAZING DISCOUNT ON REPORT @ https://www.marketresearchfuture.com/check-discount/2690 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312